Hims and Hers Health Inc vs GeneDx Holdings Corp — how do they compare? Hims and Hers Health Inc trades at $32.69 (market cap $7.57B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Hims and Hers Health Inc is far larger — about 4.2× GeneDx Holdings Corp's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| HIMS | WGS | |
|---|---|---|
Market Cap | $7.57B | $1.80B |
Sector | Health | Technology |
52-Week High | $66.18 | $167.51 |
52-Week Low | $14.52 | $34.51 |
Enterprise Value | $7.95B | $1.80B |
Trailing returns across standard periods
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →